We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Congenital CMV and Hearing Loss in Children up to 4 Years of Age: Treating With Valganciclovir Therapy

This study is currently recruiting participants.
Verified May 2017 by David Kimberlin, MD, University of Alabama at Birmingham
Sponsor:
ClinicalTrials.gov Identifier:
NCT01649869
First Posted: July 25, 2012
Last Update Posted: May 25, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Information provided by (Responsible Party):
David Kimberlin, MD, University of Alabama at Birmingham
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2019
  Estimated Primary Completion Date: September 2019 (Final data collection date for primary outcome measure)